Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71